Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 6/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.83 |
| ▸ | HPGD | P15428 | 2/20 | 0.83 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.83 |
| ▸ | MEN1 | O00255 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 1/20 | 0.83 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.83 |
| ▸ | BLM | P54132 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.83 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.83 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.80 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15008280 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 | |
| SCHEMBL31283679 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 | |
| SCHEMBL31438092 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 | |
| SCHEMBL15007722 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 | |
| SCHEMBL9964253 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 | |
| SCHEMBL31438099 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 | |
| SCHEMBL31438097 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 | |
| SCHEMBL6286826 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 | |
| SCHEMBL6286194 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 | |
| SCHEMBL6287966 | 1.00 | CNR1 (0.85) | CNR1KDM4EALDH1A1HPGDTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130089884-A1 | Protein Modification from the Oxidation of Clickable Polyunsaturated Fatty Acid Analogs | Life Technologies Corporation (US) | 2013-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130089884-A1 | Protein Modification from the Oxidation of Clickable Polyunsaturated Fatty Acid Analogs | FASN, ACSL6, FADS1 | CNR1 3923/4885KDM4E 3051/4885ALDH1A1 814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.